Investigating graft failure after heart bypass surgery
Official title: Vein Graft Failure and Cardiovascular Consequences of Coronary Artery Bypass Graft Surgery
Run by University of Edinburgh · NCT06800430 · Data updated 2026-11-12
This study looks at why heart bypass grafts fail by using special scans and tests on people who have had the surgery and those who might have problems with their grafts.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 70 (estimated) |
| Sponsor | University of Edinburgh Academic / other |
| Locations | 1 site (Edinburgh, Midlothian) |
| Status | Recruiting |
| Started | March 28, 2025 |
| Main results expected | March 28, 2027 |
| Study ends | August 6, 2027 |
| Registry record updated | April 20, 2026 |
| Trial ID | NCT06800430 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults over 18 undergoing CABG surgery with at least one saphenous vein graft or those with suspected graft vasculopathy after previous CABG.
✕Probably not a fit
Patients with a life expectancy of less than two years, renal failure, or those on immunosuppressive therapies may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational cohort study aims to understand the causes of graft failure following coronary artery bypass graft (CABG) surgery. It will utilize total-body Positron Emission Tomography (PET) scans to examine inflammation, thrombosis, and fibrosis in saphenous vein grafts. Participants will be divided into two cohorts: one undergoing CABG surgery and another with suspected vein graft failure. Clinical reviews, blood sampling, echocardiograms, and advanced imaging techniques will be employed to gather comprehensive data over time.
Why it matters
Potential benefit: If successful, this study could lead to improved understanding and management of graft failure, potentially enhancing patient outcomes after CABG surgery.
How similar studies have gone: While this approach is innovative, similar studies have shown promise in understanding graft failure, but the specific use of total-body PET imaging in this context is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
INCLUSION CRITERIA: Cohort 1: Patients undergoing CABG surgery * Males and females over 18 years of age * Patients undergoing CABG surgery for multivessel coronary artery disease, who receive at least one saphenous vein graft Cohort 2: Patients with symptomatic saphenous vein graft vasculopathy * Males and females over 18 years of age * Patients who underwent CABG surgery ≥ 5 years prior to recruitment for multivessel disease and received 2 or more saphenous vein grafts * Referred for invasive coronary angiography due to recurrent symptoms and with a high suspicion of graft vasculopathy EXCLUSION CRITERIA: * Patients with a life expectancy of \< 2 years * Renal failure (estimated glomerular filtration rate \<30 mL/min/1.73 m2) * Patients on immunosuppressive therapies * Females of child-bearing age who are pregnant or breastfeeding, * Known allergy or contraindications to iodinated contrast or radiotracer * Patients who are unable to tolerate the supine position * Patients who are unable to provide informed consent
Where it's running
-
Royal Infirmary of Edinburgh
Edinburgh, Midlothian, United Kingdom Recruiting
Study contacts
- Study coordinator: Laura E Clark, BSc, MBChB, MRCS(Ed)
- Email: lclark15@ed.ac.uk
- Phone: +447717478087
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Fasciotomy and Predilation for Radial Artery Grafts in CABG
A new way to prepare radial artery grafts during CABG is tested to see if it lowers complications and improves graft durability for adults undergoing this heart surgery.
-
See if stopping long-term aspirin is as good as continuing it in older adults with stable ischemic heart disease
In adults 65 and older with stable ischemic heart disease, this trial tests whether stopping daily low-dose aspirin is not worse than continuing it.
-
BRIDGE: Embedding consumer mHealth tools into cardiac rehab
This study tests whether adding a mobile health tool to standard center-based cardiac rehab helps heart patients stay active and follow healthy habits.
-
Differences in Outcomes After Allograft vs Autograft in Revision ACL Repair
This study looks at whether using donor tissue (allograft) versus the patient’s own tissue (autograft) in revision ACL surgery leads to different results.
-
Sustainable anesthesia for coronary artery bypass grafting
This project will test whether an 'optimized recovery' anesthesia approach for adults having elective coronary artery bypass grafting produces better environmental, clinical, and cost outcomes than standard anesthesia.
-
Global longitudinal strain to predict difficult separation from cardiopulmonary bypass
This will test whether a heart ultrasound measure called global longitudinal strain (GLS) can predict which adults having elective cardiac surgery will have trouble coming off cardiopulmonary bypass.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.